Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

6.79
-0.1100-1.59%
Post-market: 6.810.0200+0.29%17:07 EDT
Volume:65.67K
Turnover:443.03K
Market Cap:13.64M
PE:-0.80
High:6.87
Open:6.87
Low:6.66
Close:6.90
52wk High:41.80
52wk Low:3.25
Shares:2.01M
Float Shares:1.30M
Volume Ratio:0.41
T/O Rate:5.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5210
EPS(LYR):-14.7963
ROE:-575.73%
ROA:-114.60%
PB:3.47
PE(LYR):-0.46

Loading ...

Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation

TIPRANKS
·
Yesterday

Quoin Evaluates Qrx003 in Phase 2/3 Trial for Netherton Syndrome

Reuters
·
Sep 10

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

GlobeNewswire
·
Sep 10

Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003

TIPRANKS
·
Sep 08

Quoin Says FDA Grants Rare Pediatric Disease Designation for Qrx003 in Peeling Skin Syndrome

Reuters
·
Sep 08

Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)

TIPRANKS
·
Sep 04

Quoin Pharmaceuticals Director Anthony James Culverwell Acquires Shares Worth $29,988.48

Reuters
·
Sep 02

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Quoin Reports Positive Interim Phase 2/3 Data for Qrx003 in Netherton Syndrome Trial

Reuters
·
Aug 28

Quoin Pharma Prices Unregistered $50 Million Private Placement at $4.88 Per ADS

Reuters
·
Aug 28

Press Release: Quoin Pharmaceuticals Announces Private Placement Financing of up to $50.0 Million

Dow Jones
·
Aug 28

Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes

TIPRANKS
·
Aug 21

Quoin Pharmaceuticals Shareholders Approved 401(k) Matching Contribution Changes at Annual Meeting

Reuters
·
Aug 21

Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)

TIPRANKS
·
Aug 16

Quoin Pharmaceuticals Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate

Benzinga Earnings
·
Aug 14

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14

Quoin Pharmaceuticals Ltd Expected to Post a Loss of $1.61 a Share - Earnings Preview

Reuters
·
Aug 12

Quoin Pharmaceuticals Updates Financial Calendar, Sets Q2 Results Release and Corporate Update

Reuters
·
Aug 07

Quoin Pharmaceuticals Ltd Expected to Post a Loss of $1.61 a Share - Earnings Preview

Reuters
·
Aug 03